| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |